STAT3 and hepatocellular carcinoma: We observed that AC-73 notably reduced p-ERK1/2 and p-STAT3 in the two parental HCC cell lines, but not the HCC CD147−/− lines, indicating that AC-73 inhibits ERK/STAT3 signaling via specific binding to CD147.